Composition

Active: Brimonidine Tartrate 0.2% w/v Timolol Maleate IP equivalent to Timolol 0.5% w/v
Inactive Ingredients: Sodium chloride, Disodium EDTA, Sodium dihydrogen Phosphate dihydrate, Disodium hydrogen phosphate, Sodium hydroxide, Water for Injections
Preservative Added: Benzalkonium Chloride Solution 0.02% v/v

Indication
Rimoflo™ T indicated for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who are insufficiently responsive to topical Beta Blockers.

Dosage & Administration
The recommended dose is one drop of Rimoflo™ T in the affected eye(s) twice daily approximately 12 hours apart. If more than one topical ophthalmic product is to be used, the different products should be instilled at least 5 minutes apart.

Download Rimoflo™T Product Information